Cargando…
Progress in targeted therapy for breast cancer
Breast cancer is a multistep, multifactorial, and heterogeneous disease. Significant transformations have occurred in the systemic management of breast cancer in the past decade. Due to the further understanding of pathogenesis, scientists have found plenty of signaling pathways and correspondingly...
Autores principales: | Ju, Jie, Zhu, An-Jie, Yuan, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Medical Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160667/ https://www.ncbi.nlm.nih.gov/pubmed/30276363 http://dx.doi.org/10.1016/j.cdtm.2018.04.002 |
Ejemplares similares
-
Targeting MET in cancer therapy
por: Mo, Hong-Nan, et al.
Publicado: (2017) -
PPARgamma: A Potential Intrinsic and Extrinsic Molecular Target for Breast Cancer Therapy
por: Augimeri, Giuseppina, et al.
Publicado: (2021) -
Current progress in cancer treatment by targeting FGFR signaling
por: Du, Sicheng, et al.
Publicado: (2023) -
FBXO45 is a potential therapeutic target for cancer therapy
por: Lin, Min, et al.
Publicado: (2020) -
Management of breast cancer brain metastases: Focus on human epidermal growth factor receptor 2-positive breast cancer
por: Yuan, Peng, et al.
Publicado: (2017)